Showing results (311-320 of 378) with videos related to
Sort By:
Pageof 38
Bone Marrow Transplantation|November 21, 2007
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trialC Papadimitriou, U Dafni, A Anagnostopoulos, et al.European Journal of Haematology|November 1, 1991
Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantationJ C Yau, M A Dimopoulos, S D Huan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic CancerG P Stathopoulos, S K Rigatos, M A Dimopoulos, et al.Journal of Clinical Apheresis|December 22, 2000
Non-cryopreserved peripheral blood progenitor cells collected by a single very large-volume leukapheresis: a simplified and effective procedure for support of high-dose chemotherapyC A Papadimitriou, M A Dimopoulos, V Kouvelis, et al.American Journal of Hematology|December 1, 1991
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisoloneJ C Yau, M A Dimopoulos, S D Huan, et al.Anticancer Research|August 30, 2008
Microvessel density (MVD) and cyclooxygenase-2 (COX-2)/ beta-catenin interaction are associated with relapse in patients with transitional carcinoma receiving adjuvant chemotherapy with paclitaxel/carboplatin: a hellenic cooperative oncology group (HECOG) studyA Bamias, F Kyriakou, M Chorti, et al.Anticancer Research|April 1, 2009
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG)D Pectasides, G Papaxoinis, G Fountzilas, et al.British Journal of Cancer|October 18, 2007
Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implicationsH Gakiopoulou, P Korkolopoulou, G Levidou, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Thalidomide and dexamethasone combination for refractory multiple myelomaM A Dimopoulos, K Zervas, G Kouvatseas, et al.Cancer Chemotherapy and Pharmacology|September 29, 2007
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group studyE Briasoulis, G Fountzilas, A Bamias, et al.Pageof 38